Loading...
XJPX
4527
Market cap3.43bUSD
Jul 10, Last price  
2,430.00JPY
1D
-1.42%
1Q
-1.26%
Jan 2017
164.42%
Name

Rohto Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XJPX:4527 chart
P/E
16.03
P/S
1.60
EPS
151.56
Div Yield, %
1.66%
Shrs. gr., 5y
0.58%
Rev. gr., 5y
13.68%
Revenues
343.73b
+11.37%
95,619,000,000108,131,000,000110,611,000,000113,429,000,000115,472,000,000120,292,000,000129,146,000,000143,822,000,000151,774,000,000167,016,000,000154,599,000,000171,795,000,000183,672,000,000188,375,000,000181,053,000,000199,646,000,000238,664,000,000270,840,000,000308,625,000,000343,725,000,000
Net income
34.25b
+10.46%
6,617,000,0007,525,000,0006,139,000,0007,768,000,0007,966,000,0008,184,000,0008,087,000,0008,947,000,0008,631,000,0009,098,000,00010,011,000,0009,289,000,0009,800,000,00015,409,000,00016,743,000,00021,128,000,00026,377,000,00030,937,000,00031,005,000,00034,248,000,000
CFO
47.79b
+29.45%
9,358,000,00012,610,000,0007,364,000,00015,094,000,00012,924,000,00010,391,000,00016,702,000,00018,661,000,00011,292,000,00011,324,000,00013,428,000,00019,154,000,00021,745,000,00019,040,000,00020,008,000,00027,250,000,00030,924,000,00034,245,000,00036,917,000,00047,788,000,000
Dividend
Sep 29, 202625 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. Their comprehensive product line includes various ophthalmic solutions such as eye drops, contact lens care products, and eye washes. For skincare, they offer facial treatments like cleansers, toners, and creams, in addition to specialized medicated preparations for the skin. The company's offerings also extend to internal medicines, encompassing digestive aids, herbal remedies, and dietary supplements. Furthermore, they supply over-the-counter medications and deliver beauty and health services via dedicated counters. The company rebranded from Yamada Pharmaceutical to Rohto Pharmaceutical Co.,Ltd. in September 1949.
URL
https://www.rohto.co.jp/
IPO date
Oct 02, 1961
Employees
7,176
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT